Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Cytokinetics, Incorporated
Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
IPO Date: May 1, 2004
Sector: Healthcare
Industry: Biotech
Market Cap: $4.54B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.39 | 2.82%
Avg Daily Range (30 D): $0.72 | 2.06%
Avg Daily Range (90 D): $0.88 | 2.42%
Institutional Daily Volume
Avg Daily Volume: .56M
Avg Daily Volume (30 D): 1.18M
Avg Daily Volume (90 D): 1.57M
Trade Size
Avg Trade Size (Sh.): 107
Avg Trade Size (Sh.) (30 D): 55
Avg Trade Size (Sh.) (90 D): 63
Institutional Trades
Total Inst.Trades: 7,137
Avg Inst. Trade: $3.24M
Avg Inst. Trade (30 D): $3.54M
Avg Inst. Trade (90 D): $3.22M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 4
Market Closing Trades
Avg Closing Trade: $6.57M
Avg Closing Trade (30 D): $8.26M
Avg Closing Trade (90 D): $9.23M
Avg Closing Volume: 170.35K
   
News
Jun 17, 2025 @ 8:00 PM
Cytokinetics Announces Inducement Grants Under Nas...
Source: N/A
May 18, 2025 @ 12:00 PM
Cytokinetics Presents Additional Data Related to A...
Source: Cytokinetics, Incorporated
May 8, 2025 @ 8:00 PM
Cytokinetics Announces Four Upcoming Presentations...
Source: N/A
May 7, 2025 @ 8:00 PM
Cytokinetics to Hold Annual Meeting of Stockholder...
Source: N/A
May 2, 2025 @ 7:37 PM
FDA Pushes Potential Approval For Cytokinetics' Ex...
Source: Vandana Singh
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $-1.36 $-1.36
Diluted EPS $-1.36 $-1.36
Revenue $ $ 1.58M $ .46M
Gross Profit $ $ $
Net Income / Loss $ $ -161.38M $ -160.55M
Operating Income / Loss $ $ -155.63M $ -140.8M
Cost of Revenue $ $ $
Net Cash Flow $ $ -21.18M $ -143.25M
PE Ratio    
Splits
Jun 25, 2013:   1:6